Apicule is a pioneering platform revolutionizing the pharmaceutical supply chain by streamlining the sourcing and trading of Active Pharmaceutical Ingredients (APIs) also known as drug substances. As a trusted intermediary, we connect pharmaceutical manufacturers, research institutions, and healthcare providers with reputable API suppliers worldwide. Our comprehensive database and advanced search capabilities enable our clients to efficiently navigate the complex landscape of API procurement, ensuring access to high-quality ingredients that meet stringent regulatory standards. At Apicule, we understand that the quality of APIs directly impacts the safety and efficacy of final drug products. Therefore, we meticulously vet our network of suppliers, considering factors such as quality assurance, regulatory compliance, and supply chain resilience. By leveraging our expertise and cutting-edge technology, we empower our clients and drug product manufacturers to make informed decisions, mitigate risks, and ultimately contribute to the development of safe and effective medications for patients globally.
Patheon Pharma Services, a subsidiary of Thermo Fisher Scientific, is a leading Contract Development and Manufacturing Organization (CDMO) that provides comprehensive solutions for drug development, clinical trial logistics, and commercial manufacturing. Since its acquisition by hermo Fisher Scientific in 2017, Patheon has become a cornerstone of the company's Pharma Services division, offering end-to-end capabilities to pharmaceutical, biotech, and life sciences industries. Patheon Pharma Solutions has its headquarters located at 168 Third Avenue, Waltham, Massachusetts, USA 02451. - Show More
The combination of Actavis and Forest creates a new breed of specialty pharmaceutical company, with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development and a flexible, scalable business model that permits it to adap quickly to ever-changing industry dynamics and drive sustainable, long-term organic growth. - Show More
Piramal Critical Care Inc (PCC) is a leading global provider of critical care pharmaceutical products, specializing in inhaled anesthetics and hospital generics. It operates as a business division of Piramal Pharma Limited (PPL), with headquarters in Bethlehem, Pennsylvania, and strong presence in the US, Europe, and over 100 countries worldwide. - Show More
Jensen-Salsbery Laboratories was a pioneering American veterinary pharmaceutical company founded around 1913 by Dr. Hans Jensen, a pharmacist, and Dr. Charles E. Salsbery, a veterinarian. The company was incorporated in 1915 and quickly became known as "Jen-Sal," producing biolog cal products for animal health, such as vaccines and serums for diseases like rabies, botulism, pink eye, anthrax, hog cholera, and encephalomyelitis. - Show More
Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel medicines for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma-Tau places its considerable scientific resources behind the discovery of compounds that benefit the few Simply because it's the right thing to do. By maintaining an environment based on integrity, commitment, and placing the patient first, Sigma-Tau i...Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel medicines for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma-Tau places its considerable scientific resources behind the discovery of compounds that benefit the few. Simply because it's the right thing to do. By maintaining an environment based on integrity, commitment, and placing the patient first, Sigma-Tau is able to consider what may be a small commercial success nothing less than a human triumph. To us, there is no greater accomplishment than helping the little girl who is suffering from corneal cystinosis or the man with Hodgkin's lymphoma. After all, to Sigma-Tau, there's no difference between a disease that affects 300 or 300,000,000. Sigma-Tau Group is a leading research-based pharmaceutical company headquartered in Pomezia, Italy with more than 2,500 employees worldwide. Sigma-Tau Group focuses its research and development on cardiovascular disease, metabolism, oncology, immunology, and the central and peripheral nervous systems. It has 30 clinical indications studied with 17 proprietary molecules – most of which are new and original – among 47 projects. Sigma-Tau is also dedicated to creating novel therapies for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma-Tau places its considerable scientific resources behind the discovery, development and distribution of compounds that benefit the few. Sigma-Tau Group has operating subsidiaries throughout Europe and the United States and maintains a presence in all of the world’s major pharmaceutical markets. - Show More
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Nektar's R&D pipeline of new investigational drugs include treatments for cancer and auto-immune disease. The ompany leverages Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates. - Show More
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Tel Aviv, Israel. It is the largest generic drug manufacturer in the world and ranks as the 26th largest pharmaceutical company globally. Teva specializes in generic medicines, branded drugs, and active pharmaceutical ingredients (APIs). Its notable branded products include Austedo (for Huntington's disease and tardive dyskinesia) and Ajovy (for migraine prevention), among others. - Show More
At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By impr ving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base ...At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share. - Show More
